These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30803124)

  • 21. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.
    Mauracher LM; Posch F; Martinod K; Grilz E; Däullary T; Hell L; Brostjan C; Zielinski C; Ay C; Wagner DD; Pabinger I; Thaler J
    J Thromb Haemost; 2018 Mar; 16(3):508-518. PubMed ID: 29325226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study.
    Rinde LB; Lind C; Småbrekke B; Njølstad I; Mathiesen EB; Wilsgaard T; Løchen ML; Hald EM; Vik A; Braekkan SK; Hansen JB
    J Thromb Haemost; 2016 Jun; 14(6):1183-91. PubMed ID: 27061154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incident Heart Failure and Long-Term Risk for Venous Thromboembolism.
    Fanola CL; Norby FL; Shah AM; Chang PP; Lutsey PL; Rosamond WD; Cushman M; Folsom AR
    J Am Coll Cardiol; 2020 Jan; 75(2):148-158. PubMed ID: 31948643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resting heart rate and incident venous thromboembolism: the Multi-Ethnic Study of Atherosclerosis.
    Awotoye J; Fashanu OE; Lutsey PL; Zhao D; O'Neal WT; Michos ED
    Open Heart; 2020; 7(1):e001080. PubMed ID: 32153786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemostatic factors, inflammatory markers, and risk of incident venous thromboembolism: The Multi-Ethnic Study of Atherosclerosis.
    Evensen LH; Folsom AR; Pankow JS; Hansen JB; Allison MA; Cushman M; Lutsey PL
    J Thromb Haemost; 2021 Jul; 19(7):1718-1728. PubMed ID: 33773045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology.
    Steffen LM; Cushman M; Peacock JM; Heckbert SR; Jacobs DR; Rosamond WD; Folsom AR
    J Thromb Haemost; 2009 May; 7(5):746-51. PubMed ID: 19175496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study.
    Rinde LB; Morelli VM; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Wilsgaard T; Smith E; Rosendaal FR; Frazer KA; Braekkan SK; Hansen JB
    J Thromb Haemost; 2019 May; 17(5):749-758. PubMed ID: 30773804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study.
    Småbrekke B; Rinde LB; Hald EM; Njølstad I; Mathiesen EB; Johnsen SH; Hansen JB; Braekkan SK; Lijfering WM
    J Thromb Haemost; 2017 Dec; 15(12):2344-2351. PubMed ID: 28981216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
    Bjøri E; Johnsen HS; Hansen JB; Braekkan SK
    J Thromb Haemost; 2017 May; 15(5):917-924. PubMed ID: 28166605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics.
    Jensen SB; Hindberg K; Solomon T; Smith EN; Lapek JD; Gonzalez DJ; Latysheva N; Frazer KA; Braekkan SK; Hansen JB
    J Thromb Haemost; 2018 Sep; 16(9):1763-1774. PubMed ID: 29964323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceruloplasmin and atrial fibrillation: evidence of causality from a population-based Mendelian randomization study.
    Adamsson Eryd S; Sjögren M; Smith JG; Nilsson PM; Melander O; Hedblad B; Engström G
    J Intern Med; 2014 Feb; 275(2):164-71. PubMed ID: 24118451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort.
    Folsom AR; Lutsey PL; Astor BC; Cushman M
    Thromb Haemost; 2009 Oct; 102(4):615-9. PubMed ID: 19806245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population.
    Ellingsen TS; Lappegård J; Skjelbakken T; Brækkan SK; Hansen JB
    Thromb Haemost; 2015 Jan; 113(1):193-200. PubMed ID: 25274492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism and subsequent permanent work-related disability.
    Braekkan SK; Grosse SD; Okoroh EM; Tsai J; Cannegieter SC; Naess IA; Krokstad S; Hansen JB; Skjeldestad FE
    J Thromb Haemost; 2016 Oct; 14(10):1978-1987. PubMed ID: 27411161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).
    Folsom AR; Tang W; George KM; Heckbert SR; MacLehose RF; Cushman M; Pankow JS
    Thromb Res; 2016 Mar; 139():44-9. PubMed ID: 26916295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
    Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
    J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism.
    Gran OV; Braekkan SK; Paulsen B; Skille H; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2017 Jul; 15(7):1361-1367. PubMed ID: 28440069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism.
    Hansen ES; Hindberg K; Latysheva N; Aukrust P; Ueland T; Hansen JB; Brækkan SK; Morelli VM;
    Blood; 2020 Oct; 136(16):1863-1870. PubMed ID: 32645137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.
    Reiner MF; Stivala S; Limacher A; Bonetti NR; Méan M; Egloff M; Rodondi N; Aujesky D; von Schacky C; Lüscher TF; Camici GG; Beer JH
    J Thromb Haemost; 2017 Jan; 15(1):47-56. PubMed ID: 27790827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein(a) is not associated with venous thromboembolism risk.
    Kunutsor SK; Mäkikallio TH; Kauhanen J; Voutilainen A; Laukkanen JA
    Scand Cardiovasc J; 2019 Jun; 53(3):125-132. PubMed ID: 31032650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.